Stephen Betz
Founder presso CRINETICS PHARMACEUTICALS, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Stephen F.
Betz is the founder.
He founded Crinetics Pharmaceuticals, Inc. in 2008 and currently holds the title of Chief Scientific Officer.
He previously worked at Neurocrine Biosciences, Inc. from 2003 to 2009, where he held the position of Director-Endocrinology & Metabolism.
Before that, he worked at GeneFormatics, Inc. from 2001 to 2003 as the Head-Laboratory Efforts.
Mr. Betz completed his undergraduate degree at the University of Delaware in 1987.
He then went on to earn his doctorate degree from The University of North Carolina at Chapel Hill in 1993.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2024 | 92 643 ( 0.12% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Stephen Betz
| Società | Posizione | Inizio |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Founder | 01/01/2008 |
Precedenti posizioni note di Stephen Betz
| Società | Posizione | Fine |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2009 |
| GeneFormatics, Inc. | Corporate Officer/Principal | 01/01/2003 |
Formazione di Stephen Betz
| University of Delaware | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
| GeneFormatics, Inc. | Health Technology |
- Borsa valori
- Insiders
- Stephen Betz
